U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07107516) titled 'Phase 1b Ascending Dose Study of PanChol in Healthy Volunteers' on July 30.
Brief Summary: Cholera is a serious diarrheal disease that can be fatal within hours of onset. The current available cholera vaccines to prevent the disease are not very effective. Panchol is a new oral cholera vaccine that may be an improvement over the currently vaccines in use. The goal of this study is to learn safety of this new oral cholera vaccine and the body's immune response to the vaccine.
The researchers will compare the PanChol vaccine to placebo to see the side effects experienced in participants.
The participants will be adults aged between 1...